SIrolimus
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33694 publications
Rapamycin Differentially Impacts Germline Stem Cell Quiescence Across Diverse Genetic Backgrounds of Drosophila Melanogaster.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2026
Orbital Epstein-Barr virus associated smooth muscle tumor in an immunocompromised patient with T-cell deficiency.
Journal: Orbit (Amsterdam, Netherlands)
Published: January 21, 2026
Dietary arginine modulates egg production and mTOR signalling pathway gene expression in adult Japanese quail (Coturnix japonica).
Journal: Veterinary and animal science
Published: January 21, 2026
mTORC1 inhibitors rapamycin and everolimus as host-directed therapy for tuberculosis.
Journal: Infection and immunity
Published: January 21, 2026
Targeting the TORC1/TORC2 Signaling Hub MoLst8 Cripples Fungal Pathogenesis and Reveals TF3 as a Novel Selective Inhibitor.
Journal: Journal of agricultural and food chemistry
Published: January 19, 2026
The combination of BCL-xL PROTAC and mTOR inhibitor sensitizes pancreatic ductal adenocarcinoma to KRAS G12D inhibitor treatment by enhancing apoptosis induction.
Journal: bioRxiv : the preprint server for biology
Published: January 16, 2026
The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets.
Journal: Research square
Published: January 16, 2026
Advances in autophagy for Parkinson's disease pathogenesis and treatment.
Journal: Ageing and neurodegenerative diseases
Published: January 15, 2026
RETRACTION: Autophagy Regulates the Apoptosis of Bone Marrow-Derived Mesenchymal Stem Cells Under Hypoxic Condition via AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Journal: Cell biology international
Published: January 14, 2026
Muscle meets Lysosomes: emerging strategies in muscular dystrophy.
Journal: Autophagy
Published: January 14, 2026
An update on the treatment paradigm for non-clear cell renal cell carcinoma.
Journal: Expert review of clinical pharmacology
Published: January 10, 2026
Thioredoxin interacting protein (TXNIP), a redox regulator, mediates the RAPGEF3/4 signaling dependency in primary melanoma.
Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026
Last Updated: 02/24/2026